{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:17:09Z","timestamp":1773209829972,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T00:00:00Z","timestamp":1714262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T00:00:00Z","timestamp":1714262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","award":["RT-2020-0516"],"award-info":[{"award-number":["RT-2020-0516"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Autism Dev Disord"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10803-024-06344-z","type":"journal-article","created":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T14:01:16Z","timestamp":1714312876000},"page":"2512-2521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prescriptions for Antipsychotics: Youth with Intellectual\/Developmental Disabilities Compared to Youth without Intellectual\/Developmental Disabilities"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4830-3556","authenticated-orcid":false,"given":"Sandra","family":"Marquis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. Esm\u00e9","family":"Marquis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yona","family":"Lunsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberlyn M.","family":"McGrail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Baumbusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,28]]},"reference":[{"issue":"2","key":"6344_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.23889\/ijpds.v4i2.1133","volume":"4","author":"TK Ark","year":"2020","unstructured":"Ark, T. K., Kesselring, S., Hills, B., & McGrail, K. M. (2020). Population Data BC: Supporting population data science in British Columbia. International Journal of Population Data Science, 4(2), 14. https:\/\/doi.org\/10.23889\/ijpds.v4i2.1133.","journal-title":"International Journal of Population Data Science"},{"key":"6344_CR2","unstructured":"ATC\/DDD Index (2023). (2023). World Health Organization Centre for Drug Statistics Mehodology. https:\/\/www.whocc.no\/atc_ddd_index\/."},{"issue":"6","key":"6344_CR3","doi-asserted-by":"publisher","first-page":"e0199218","DOI":"10.1371\/journal.pone.0199218","volume":"13","author":"A Axmon","year":"2018","unstructured":"Axmon, A., Sandberg, M., Ahlstr\u00f6, G., & Midl\u00f6, P. (2018). Fall-risk-increasing drugs and falls requiring health care among older people with intellectual disability in comparison with the general population: A register study. Plos One, 13(6), e0199218. https:\/\/doi.org\/10.1371\/journal.pone.0199218.","journal-title":"Plos One"},{"issue":"3","key":"6344_CR4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/josi.12354","volume":"75","author":"KR Bogart","year":"2019","unstructured":"Bogart, K. R., & Dunn, D. S. (2019). Ableism Special issue introduction. Journal of Social Issues, 75(3), 650\u2013664. https:\/\/doi.org\/10.1111\/josi.12354.","journal-title":"Journal of Social Issues"},{"key":"6344_CR5","doi-asserted-by":"publisher","first-page":"101642","DOI":"10.1016\/j.rasd.2020.101642","volume":"78","author":"N Bowden","year":"2020","unstructured":"Bowden, N., Thabrew, H., Kokaua, J., & Braund, R. (2020). National prescribing rates and polypharmacy for children and young people in New Zealand with and without autism spectrum disorder. Research in Autism Spectrum Disorders, 78, 101642. https:\/\/doi.org\/10.1016\/j.rasd.2020.101642.","journal-title":"Research in Autism Spectrum Disorders"},{"issue":"6","key":"6344_CR6","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/JIR.12359","volume":"61","author":"DL Bowring","year":"2017","unstructured":"Bowring, D. L., Totsika, V., Hastings, R. P., Toogood, S., & McMahon, M. (2017). Prevalence of psychotropic medication use and association with challenging behaviour in adults with an intellectual disability. A total population study. Journal of Intellectual Disability Research, 61(6), 604\u2013617. https:\/\/doi.org\/10.1111\/JIR.12359.","journal-title":"Journal of Intellectual Disability Research"},{"key":"6344_CR7","doi-asserted-by":"publisher","unstructured":"Brylewski, J., & Duggan, L. (2004). Antipsychotic medication for challenging behaviour in people with learning disability. Cochrane Database of Systematic Reviews, 3. https:\/\/doi.org\/10.1002\/14651858.cd000377.pub2.","DOI":"10.1002\/14651858.cd000377.pub2"},{"issue":"5","key":"6344_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/DBP.0000000000001044","volume":"43","author":"B Caplan","year":"2022","unstructured":"Caplan, B., Chlebowski, C., May, G., Baker-Ericz\u00e9n, M. J., Connor, W., & Brookman-Frazee, L. (2022). Psychotropic medication use by children with autism served in publicly funded mental health settings. Journal of Developmental and Behavioral Pediatrics, 43(5), 252\u2013261. https:\/\/doi.org\/10.1097\/DBP.0000000000001044.","journal-title":"Journal of Developmental and Behavioral Pediatrics"},{"key":"6344_CR9","unstructured":"Challenging behaviour and learning disabilities: Prevention and interventions for people with learning disabilities whose behaviour challenges. (2015). National Institute for Health and Care Excellence (NICE Guidance); NICE. https:\/\/www.nice.org.uk\/guidance\/ng11\/chapter\/Recommendations#psychological-and-environmental-interventions."},{"key":"6344_CR10","unstructured":"Chokhawala, K., & Stevens, L. (2023, February 26). Antipsychotic medications. StatPearls; StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519503\/."},{"issue":"10","key":"6344_CR11","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/jpc.14197","volume":"54","author":"RC Cvejic","year":"2018","unstructured":"Cvejic, R. C., & Trollor, J. N. (2018). Transition to adult mental health services for young people with an intellectual disability. Journal of Paediatrics and Child Health, 54(10), 1127\u20131130. https:\/\/doi.org\/10.1111\/jpc.14197.","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"10","key":"6344_CR13","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/JIR.12385","volume":"61","author":"GM de Kuijper","year":"2017","unstructured":"de Kuijper, G. M., & Hoekstra, P. J. (2017). Physicians\u2019 reasons not to discontinue long-term used off-label antipsychotic drugs in people with intellectual disability. Journal of Intellectual Disability Research, 61(10), 899\u2013908. https:\/\/doi.org\/10.1111\/JIR.12385.","journal-title":"Journal of Intellectual Disability Research"},{"issue":"7","key":"6344_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/J.1365-2788.2010.01275.X","volume":"54","author":"G de Kuijper","year":"2010","unstructured":"de Kuijper, G., Hoekstra, P., Visser, F., Scholte, F. A., Penning, C., & Evenhuis, H. (2010). Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: Prevalence and reasons for prescription. Journal of Intellectual Disability Research, 54(7), 659\u2013667. https:\/\/doi.org\/10.1111\/J.1365-2788.2010.01275.X.","journal-title":"Journal of Intellectual Disability Research"},{"issue":"8","key":"6344_CR14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/DBP.0000000000000179","volume":"36","author":"A Downes","year":"2015","unstructured":"Downes, A., Anixt, J. S., Esbensen, A. J., Wiley, S., & Meinzen-Derr, J. (2015). Psychotropic medication use in children and adolescents with Down syndrome. Journal of Developmental and Behavioral Pediatrics, 36(8), 613\u2013619. https:\/\/doi.org\/10.1097\/DBP.0000000000000179.","journal-title":"Journal of Developmental and Behavioral Pediatrics"},{"key":"6344_CR15","doi-asserted-by":"crossref","unstructured":"Emerson, E., Totsika, V., Hatton, C., & Hastings, R. P. (2023). The mental health and wellbeing of adolescents with\/without intellectual disability in the UK. Epidemiology and Psychiatric Services.","DOI":"10.1017\/S204579602300080X"},{"key":"6344_CR16","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s10803-009-0750-3","volume":"39","author":"AJ Esbensen","year":"2009","unstructured":"Esbensen, A. J., Greenberg, J. S., Seltzer, M. M., & Aman, M. G. (2009). A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders. Journal of Autism and Developmental Disorders, 39, 1339\u20131349. https:\/\/doi.org\/10.1007\/s10803-009-0750-3.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"6344_CR17","doi-asserted-by":"publisher","first-page":"e036862","DOI":"10.1136\/bmjopen-2020-036862","volume":"10","author":"A Henderson","year":"2020","unstructured":"Henderson, A., Mcskimming, P., Kinnear, D., Mccowan, C., Mcintosh, A., Allan, L., & Cooper, S. A. (2020). Changes over a decade in psychotropic prescribing for people with intellectual disabilities: Prospective cohort study. British Medical Journal Open, 10, e036862. https:\/\/doi.org\/10.1136\/bmjopen-2020-036862.","journal-title":"British Medical Journal Open"},{"key":"6344_CR18","doi-asserted-by":"publisher","unstructured":"Hirsch, L. E., & Pringsheim, T. (2016). Aripiprazole for autism spectrum disorders (ASD). In Cochrane Database of Systematic Reviews (Vol. 6, Issue CD009043). John Wiley and Sons Ltd. https:\/\/doi.org\/10.1002\/14651858.CD009043.PUB3.","DOI":"10.1002\/14651858.CD009043.PUB3"},{"issue":"9","key":"6344_CR19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/jir.12100","volume":"58","author":"K Hsieh","year":"2014","unstructured":"Hsieh, K., Rimmer, J. H., & Heller, T. (2014). Obesity and associated factors in adults with intellectual disability. Journal of Intellectual Disability Research, 58(9), 851\u2013863. https:\/\/doi.org\/10.1111\/jir.12100.","journal-title":"Journal of Intellectual Disability Research"},{"issue":"1","key":"6344_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/09687590500375366","volume":"21","author":"B Hudson","year":"2006","unstructured":"Hudson, B. (2006). Making and missing connections: Learning disability services and the transition from adolescence to adulthood. Disability and Society, 21(1), 47\u201360. https:\/\/doi.org\/10.1080\/09687590500375366.","journal-title":"Disability and Society"},{"key":"6344_CR21","doi-asserted-by":"publisher","unstructured":"Ip, A., Zwaigenbaum, L., & Brian, J. A. (2019). Post-diagnostic management and follow-up care for autism spectrum disorder. Paediatrics and Child Health, 461\u2013468. https:\/\/doi.org\/10.1093\/pch\/pxz121.","DOI":"10.1093\/pch\/pxz121"},{"key":"6344_CR22","doi-asserted-by":"publisher","first-page":"623681","DOI":"10.3389\/fpsyt.2021.623681","volume":"12","author":"MR Libowitz","year":"2021","unstructured":"Libowitz, M. R., & Nurmi, E. L. (2021). The burden of antipsychotic-induced weight gain and metabolic syndrome in children. Frontiers in Psychiatry, 12, 623681. https:\/\/doi.org\/10.3389\/fpsyt.2021.623681.","journal-title":"Frontiers in Psychiatry"},{"issue":"5","key":"6344_CR23","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/jir.12002","volume":"57","author":"E Lin","year":"2013","unstructured":"Lin, E., Balogh, R., Cobigo, V., Ouellette-Kuntz, H., Wilton, A. S., & Lunsky, Y. (2013). Using administrative health data to identify individuals with intellectual and developmental disabilities: A comparison of algorithms. Journal of Intellectual Disability Research, 57(5), 462\u2013477. https:\/\/doi.org\/10.1111\/jir.12002.","journal-title":"Journal of Intellectual Disability Research"},{"key":"6344_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01541-5","author":"C Lord","year":"2021","unstructured":"Lord, C., Charman, T., Havdahl, A., Carbone, P., Anagnostou, E., Boyd, B., Carr, T., de Vries, P. J., Dissanayake, C., Divan, G., Freitag, C. M., Gotelli, M. M., Kasari, C., Knapp, M., Mundy, P., Plank, A., Scahill, L., Servili, C., Shattuck, P., & McCauley, J. B. (2021). The Lancet Commission on the future of care and clinical research in autism. The Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(21)01541-5.","journal-title":"The Lancet"},{"key":"6344_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0140-6736(21)01541-5","volume":"399","author":"C Lord","year":"2022","unstructured":"Lord, C., Charman, T., Havdahl, A., Carbone, P., Anagnostou, E., Boyd, B., Carr, T., De Vries, P. J., Dissanayake, C., Divan, G., Freitag, C. M., Gotelli, M. M., Kasari, C., Knapp, M., Mundy, P., Plank, A., Scahill, L., Servili, C., Shattuck, P., & Mccauley, J. B. (2022). The Lancet Commission on the future of care and clinical research in autism. The Lancet, 399, 271\u2013334. https:\/\/doi.org\/10.1016\/S0140-6736(21)01541-5.","journal-title":"The Lancet"},{"issue":"8","key":"6344_CR26","doi-asserted-by":"publisher","first-page":"CD008559","DOI":"10.1002\/14651858.CD008559.PUB3","volume":"8","author":"JH Loy","year":"2017","unstructured":"Loy, J. H., Merry, S. N., Hetrick, S. E., & Stasiak, K. (2017). Atypical antipsychotics for disruptive behaviour disorders in children and youths. The Cochrane Database of Systematic Reviews, 8(8), CD008559\u2013CD008559. https:\/\/doi.org\/10.1002\/14651858.CD008559.PUB3.","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"6","key":"6344_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1177\/0706743717727240","volume":"63","author":"Y Lunsky","year":"2017","unstructured":"Lunsky, Y., Khuu, W., Tadrous, M., Vigod, S., Cobigo, V., & Gomes, T. (2017). Antipsychotic use with and without comorbid psychiatric diagnosis among adults with intellectual and developmental disabilities. Canadian Journal of Psychiatry, 63(6), 361\u2013369. https:\/\/doi.org\/10.1177\/0706743717727240.","journal-title":"Canadian Journal of Psychiatry"},{"issue":"4","key":"6344_CR28","doi-asserted-by":"publisher","first-page":"538","DOI":"10.2174\/1570159x18666200529151741","volume":"19","author":"BJ Mano-Sousa","year":"2021","unstructured":"Mano-Sousa, B. J., Pedrosa, A. M., Alves, B. C., Galdur\u00f3z, J. C. F., Belo, V. S., Chaves, V. E., & Duarte-Almeida, J. M. (2021). Effects of risperidone in autistic children and young adults: A systematic review and meta-analysis. Current Neuropharmacology, 19(4), 538\u2013552. https:\/\/doi.org\/10.2174\/1570159x18666200529151741.","journal-title":"Current Neuropharmacology"},{"key":"6344_CR29","doi-asserted-by":"publisher","unstructured":"Marquis, S., Lunsky, Y., McGrail, K., & Baumbusch, J. (2024). Population level mental health diagnoses for youth with intellectual\/developmental disabilities compared to youth without intellectual\/developmental disabilities. Research on Child and Adolescent Psychopathology, 2\u201311. https:\/\/doi.org\/10.1007\/s10802-024-01174-0.","DOI":"10.1007\/s10802-024-01174-0"},{"key":"6344_CR30","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1176\/appi.ps.201900465","volume":"72","author":"JL McLaren","year":"2021","unstructured":"McLaren, J. L., Lichtenstein, J. D., Metcalfe, J. D., Charlot, L. R., Drake, R. E., & Beasley, J. B. (2021). Psychotropic use among youths with intellectual and developmental disabilities. Psychiatric Services, 72, 988\u2013997. https:\/\/doi.org\/10.1176\/appi.ps.201900465.","journal-title":"Psychiatric Services"},{"issue":"8","key":"6344_CR31","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jamapsychiatry.2018.1088","volume":"75","author":"GE Nicol","year":"2018","unstructured":"Nicol, G. E., Yingling, M. D., Flavin, K. S., Schweiger, J. A., Patterson, B. W., Schechtman, K. B., & Newcomer, J. W. (2018). Metabolic effects of antipsychotics on adiposity and insulin sensitivity in youths. A randomized clinical trial. JAMA Psychiatry, 75(8), 788\u2013796. https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.1088.","journal-title":"JAMA Psychiatry"},{"key":"6344_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/bld.12206","volume":"46","author":"A Niven","year":"2018","unstructured":"Niven, A., Goodey, R., Webb, A., & Shankar, R. (2018). The use of psychotropic medication for people with intellectual disabilities and behaviours that challenge in the context of a community multidisciplinary team approach. British Journal of Learning Disabilities, 46, 4\u20139. https:\/\/doi.org\/10.1111\/bld.12206.","journal-title":"British Journal of Learning Disabilities"},{"issue":"6","key":"6344_CR33","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1046\/J.1365-2788.2003.00511.X","volume":"47","author":"JA N\u00f8ttestad","year":"2003","unstructured":"N\u00f8ttestad, J. A., & Linaker, O. M. (2003). Psychotropic drug use among people with intellectual disability before and after deinstitutionalization. Journal of Intellectual Disability Research, 47(6), 464\u2013471. https:\/\/doi.org\/10.1046\/J.1365-2788.2003.00511.X.","journal-title":"Journal of Intellectual Disability Research"},{"issue":"8","key":"6344_CR34","first-page":"291","volume":"65","author":"A Ooi","year":"2023","unstructured":"Ooi, A., Banno, B., McFee, K., Elbe, D., & Friedlander, R. (2023). Evaluating and managing irritability and aggression in children and adolescents with autism spectrum disorder: An algorithm. British Columbia Medical Journal, 65(8), 291\u2013301.","journal-title":"British Columbia Medical Journal"},{"key":"6344_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/2955772","author":"R Oyetoro","year":"2023","unstructured":"Oyetoro, R., Wiemer, L., Bardhi, O., Louis, M., & Jacob, R. (2023). Special considerations for management of diabetes in adult patients with intellectual and developmental disabilities. Advances in Medicine. https:\/\/doi.org\/10.1155\/2023\/2955772.","journal-title":"Advances in Medicine"},{"issue":"6","key":"6344_CR36","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jaac.2016.03.012","volume":"55","author":"SY Park","year":"2016","unstructured":"Park, S. Y., Cervesi, C., Galling, B., Molteni, S., Walyzada, F., Ameis, S. H., Gerhard, T., Olfson, M., & Correll, C. U. (2016). Antipsychotic use trends in youth with Autism Spectrum Disorder and\/or intellectual disability: A meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 55(6), 456\u2013468. www.jaacap.org.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"6344_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-023-06182-5","author":"JE Rast","year":"2023","unstructured":"Rast, J. E., Tao, S., Schott, W., Shea, L. L., Brodkin, E. S., Kerns, C. M., Leonard, C. E., Murray, M. J., & Lee, B. K. (2023). Psychotropic medication use in children and youth with autism enrolled in Medicaid. Journal of Autism and Developmental Disorders. https:\/\/doi.org\/10.1007\/s10803-023-06182-5.","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"4","key":"6344_CR38","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/jar.12183","volume":"29","author":"A Scheifes","year":"2016","unstructured":"Scheifes, A., Egberts, T. C. G., Stolker, J. J., Nijman, H. L. I., & Heerdink, E. R. (2016). Structured medication review to improve pharmacotherapy in people with intellectual disability and behavioural problems. Journal of Applied Research in Intellectual Disabilities, 29(4), 346\u2013355. https:\/\/doi.org\/10.1111\/jar.12183. https:\/\/onlinelibrary-wiley-com.ezproxy.library.uvic.ca\/doi\/full\/.","journal-title":"Journal of Applied Research in Intellectual Disabilities"},{"key":"6344_CR39","doi-asserted-by":"publisher","first-page":"h4326","DOI":"10.1136\/bmj.h4326","volume":"351","author":"R Sheehan","year":"2015","unstructured":"Sheehan, R., Hassiotis, A., Walters, K., Osborn, D., Strydom, A., & Horsfall, L. (2015). Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK Population based cohort study. Bmj, 351, h4326. https:\/\/doi.org\/10.1136\/bmj.h4326.","journal-title":"Bmj"},{"key":"6344_CR40","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/TCRM.S117321","volume":"13","author":"M Solmi","year":"2017","unstructured":"Solmi, M., Murru, A., Pacchiarotti, I., Undurraga, J., Veronese, N., Fornaro, M., Stubbs, B., Monaco, F., Vieta, E., Vseeman, M., Correll, C. U., & Carvalho, A. F. (2017). Safety, tolerability, and risks associated with first-and second-generation antipsychotics: A state-of-the-art clinical review. Therapeutics and Clinical Risk Management, 13, 757\u2013777. https:\/\/doi.org\/10.2147\/TCRM.S117321.","journal-title":"Therapeutics and Clinical Risk Management"},{"issue":"10","key":"6344_CR41","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1001\/ARCHPEDI.155.10.1153","volume":"155","author":"DW Spady","year":"2001","unstructured":"Spady, D. W., Schopflocher, D. P., Svenson, L. W., & Thompson, A. H. (2001). Prevalence of mental disorders in children living in Alberta, Canada, as determined from physician billing data. Archives of Pediatrics & Adolescent Medicine, 155(10), 1153\u20131159. https:\/\/doi.org\/10.1001\/ARCHPEDI.155.10.1153.","journal-title":"Archives of Pediatrics & Adolescent Medicine"},{"key":"6344_CR42","unstructured":"Statistical Analysis System Version 9.4. (n.d.). In SAS Institute Inc"},{"key":"6344_CR43","unstructured":"Stopping over medication of people with a learning disability, autism or both (STOMP). (n.d.). Retrieved May 27, (2023). from https:\/\/www.england.nhs.uk\/learning-disabilities\/improving-health\/stomp\/."},{"issue":"4","key":"6344_CR44","first-page":"254","volume":"64","author":"WF Sullivan","year":"2018","unstructured":"Sullivan, W. F., Diepstra, H., Heng, J., Ally, S., Bradley, E., Casson, I., Hennen, B., Kelly, M., Korossy, M., McNeil, K., Abells, D., Amaria, K., Boyd, K., Gemmill, M., Grier, E., Kennie-Kaulbach, N., Ketchell, M., Ladouceur, J., Lepp, A., & Witherbee, S. (2018). Primary care of adults with intellectual and developmental disabilities: 2018 Canadian consensus guidelines. Canadian Family Physician, 64(4), 254\u2013279. https:\/\/www.pmc.com\/articles\/PMC5897068.","journal-title":"Canadian Family Physician"},{"issue":"4","key":"6344_CR45","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1177\/1362361320982819","volume":"25","author":"A Tint","year":"2021","unstructured":"Tint, A., Brown, H. K., Chen, S., Lai, M. C., Tarasoff, L. A., Vigod, S. N., Parish, S., Havercamp, S. M., & Lunsky, Y. (2021). Health characteristics of reproductive-aged autistic women in Ontario: A population-based, cross-sectional study. Autism, 25(4), 1114\u20131124. https:\/\/doi.org\/10.1177\/1362361320982819.","journal-title":"Autism"},{"key":"6344_CR46","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00787-020-01614-4","volume":"30","author":"CCL van der Esch","year":"2021","unstructured":"van der Esch, C. C. L., Kloosterboer, S. M., van der Ende, J., Reichart, C. G., Kouijzer, M. E. J., De Kroon, M. M. J., van Daalen, E., Ester, W. A., Rieken, R., Dieleman, G. C., Hillegers, M. H. J., van Gelder, T., Koch, B. C. P., & Dierckx, B. (2021). Risk factors and pattern of weight gain in youths using antipsychotic drugs. European Child and Adolescent Psychiatry, 30, 1263\u20131271. https:\/\/doi.org\/10.1007\/s00787-020-01614-4.","journal-title":"European Child and Adolescent Psychiatry"},{"key":"6344_CR47","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jpeds.2021.01.043","volume":"232","author":"LD Wiggins","year":"2021","unstructured":"Wiggins, L. D., Nadler, C., Rosenberg, S., Moody, E., Reyes, N., Reynolds, A., Alexander, A., Daniels, J., Thomas, K., Giarelli, E., & Levy, S. E. (2021). Many young children with autism who use psychotropic medication do not receive behavior therapy: A multisite case-control study. The Journal of Pediatrics, 232, 264\u2013271. https:\/\/doi.org\/10.1016\/j.jpeds.2021.01.043.","journal-title":"The Journal of Pediatrics"},{"issue":"5","key":"6344_CR48","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/jar.12286","volume":"30","author":"G Young-Southward","year":"2017","unstructured":"Young-Southward, G., Philo, C., & Cooper, S. A. (2017). What effect does transition have on health and well-being in young people with intellectual disabilities? A systematic review. Journal of Applied Research in Intellectual Disabilities, 30(5), 805\u2013823. https:\/\/doi.org\/10.1111\/jar.12286.","journal-title":"Journal of Applied Research in Intellectual Disabilities"}],"container-title":["Journal of Autism and Developmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-024-06344-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10803-024-06344-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-024-06344-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T06:41:11Z","timestamp":1749883271000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10803-024-06344-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,28]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["6344"],"URL":"https:\/\/doi.org\/10.1007\/s10803-024-06344-z","relation":{},"ISSN":["0162-3257","1573-3432"],"issn-type":[{"value":"0162-3257","type":"print"},{"value":"1573-3432","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,28]]},"assertion":[{"value":"2 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}},{"value":"the authors have no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing Interests"}},{"value":"All inferences, opinions, and conclusions drawn in this publication are those of the author(s), and do not reflect the opinions or policies of the Data Steward.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"The B.C. Ministry of Health provided approval for data access and the Research Ethics Board of the University of British Columbia, Vancouver, BC, Canada provided ethics approval (#H20-03028).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"Administrative data was used, there were no experiments performed on humans or animals. No consent was required from patients whose data was used because the data is anonymized administrative health data collected for billing purposes by physicians and submitted to the BC Ministry of Health.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}